NCT00001764View on ClinicalTrials.gov

Mycophenolate Mofetil to Treat Wegener's Granulomatosis and Related Vascular Inflammatory Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

April 30, 1998

Study Completion Date

June 30, 2004

Conditions
VasculitisWegener's Granulomatosis
Interventions
DRUG

Mycophenolate Mofetil

Trial Locations (1)

20892

National Institute of Allergy and Infectious Diseases (NIAID), Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00001764 - Mycophenolate Mofetil to Treat Wegener's Granulomatosis and Related Vascular Inflammatory Conditions | Biotech Hunter | Biotech Hunter